
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.8B | $3B | $3.5B | $3.7B | |
Revenue Growth (YoY) | 4.61% | 12.8% | 9.1% | 15.2% | 6% | |
Cost of Revenues | $1.7B | $1.9B | $2.1B | $2.4B | $2.5B | |
Gross Profit | $788.6M | $860.7M | $962.9M | $1.1B | $1.2B | |
Gross Profit Margin | 32.04% | 31% | 31.79% | 32.53% | 31.96% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $488.4M | $537.8M | $641.1M | $751.3M | $822.2M | |
Other Inc / (Exp) | -$8.5M | $2.7M | -$9M | -$10.1M | -$6.3M | |
Operating Expenses | $501.6M | $548.7M | $650.7M | $757.5M | $826.3M | |
Operating Income | $287M | $312M | $312.2M | $377.6M | $355.6M | |
Net Interest Expenses | $16.1M | $16.8M | $5.4M | $9.1M | -- | |
EBT. Incl. Unusual Items | $262.4M | $297.9M | $297.7M | $358.4M | $350.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $51.8M | $63M | $62.2M | $83.5M | $70.7M | |
Net Income to Company | $210.7M | $235M | $235.5M | $274.9M | $280.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $210.7M | $235M | $235.5M | $274.9M | $280.1M | |
Basic EPS (Cont. Ops) | $5.92 | $7.02 | $6.99 | $8.10 | $7.96 | |
Diluted EPS (Cont. Ops) | $5.67 | $6.65 | $6.58 | $7.71 | $7.81 | |
Weighted Average Basic Share | $35.6M | $33.5M | $33.7M | $33.9M | $35.2M | |
Weighted Average Diluted Share | $37.1M | $35.3M | $35.8M | $35.6M | $35.8M | |
EBITDA | $325.3M | $363.3M | $353.3M | $419.9M | $405.8M | |
EBIT | $282.3M | $318.2M | $307.8M | $372.7M | $357.7M | |
Revenue (Reported) | $2.5B | $2.8B | $3B | $3.5B | $3.7B | |
Operating Income (Reported) | $287M | $312M | $312.2M | $377.6M | $355.6M | |
Operating Income (Adjusted) | $282.3M | $318.2M | $307.8M | $372.7M | $357.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $686.3M | $723.6M | $806.7M | $928.6M | $898.3M | |
Revenue Growth (YoY) | 13.51% | 5.44% | 11.48% | 15.1% | -3.26% | |
Cost of Revenues | $468.4M | $493.1M | $553.5M | $626M | $608.9M | |
Gross Profit | $217.9M | $230.5M | $253.2M | $302.5M | $289.4M | |
Gross Profit Margin | 31.74% | 31.86% | 31.39% | 32.58% | 32.21% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $126.5M | $149M | $184.2M | $201.9M | $184.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$25.3M | |
Operating Expenses | $129.3M | $151.2M | $186.4M | $202.9M | $185.4M | |
Operating Income | $88.5M | $79.3M | $66.8M | $99.6M | $104M | |
Net Interest Expenses | $3.8M | $3M | $4.3M | $138K | -- | |
EBT. Incl. Unusual Items | $84.7M | $76.3M | $62.5M | $99.5M | $80.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.2M | $17M | $15M | $19.5M | $18.8M | |
Net Income to Company | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Basic EPS (Cont. Ops) | $1.93 | $1.76 | $1.43 | $2.29 | $1.76 | |
Diluted EPS (Cont. Ops) | $1.84 | $1.66 | $1.34 | $2.23 | $1.74 | |
Weighted Average Basic Share | $33.5M | $33.6M | $33.3M | $35M | $35.1M | |
Weighted Average Diluted Share | $35.1M | $35.6M | $35.5M | $35.8M | $35.5M | |
EBITDA | $100.5M | $90.5M | $78.4M | $112.7M | $92.7M | |
EBIT | $89.5M | $79.3M | $66.8M | $101.2M | $81.5M | |
Revenue (Reported) | $686.3M | $723.6M | $806.7M | $928.6M | $898.3M | |
Operating Income (Reported) | $88.5M | $79.3M | $66.8M | $99.6M | $104M | |
Operating Income (Adjusted) | $89.5M | $79.3M | $66.8M | $101.2M | $81.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.8B | $3.1B | $3.6B | $3.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.7B | $1.9B | $2.1B | $2.4B | $2.5B | |
Gross Profit | $804.1M | $873.4M | $985.6M | $1.2B | $1.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $488M | $560.3M | $676.3M | $769M | $804.6M | |
Other Inc / (Exp) | -$11.3M | -- | -- | -- | -$25.3M | |
Operating Expenses | $498.9M | $570.6M | $685.9M | $774M | $808.8M | |
Operating Income | $305.2M | $302.8M | $299.7M | $410.4M | $360M | |
Net Interest Expenses | $20M | $16M | $6.7M | $5M | -- | |
EBT. Incl. Unusual Items | $274M | $289.5M | $284M | $395.3M | $331.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $55.5M | $59.7M | $60.2M | $88M | $69.9M | |
Net Income to Company | $218.4M | $229.8M | $223.7M | $307.3M | $261.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $218.4M | $229.8M | $223.7M | $307.3M | $261.9M | |
Basic EPS (Cont. Ops) | $6.30 | $6.85 | $6.66 | $8.95 | $7.43 | |
Diluted EPS (Cont. Ops) | $6.03 | $6.46 | $6.25 | $8.60 | $7.31 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $340.9M | $354.2M | $341.7M | $456.1M | $386.8M | |
EBIT | $297.1M | $308.9M | $295.7M | $409M | $339M | |
Revenue (Reported) | $2.5B | $2.8B | $3.1B | $3.6B | $3.7B | |
Operating Income (Reported) | $305.2M | $302.8M | $299.7M | $410.4M | $360M | |
Operating Income (Adjusted) | $297.1M | $308.9M | $295.7M | $409M | $339M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $686.3M | $723.6M | $806.7M | $928.6M | $898.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $468.4M | $493.1M | $553.5M | $626M | $608.9M | |
Gross Profit | $217.9M | $230.5M | $253.2M | $302.5M | $289.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $126.5M | $149M | $184.2M | $201.9M | $184.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$25.3M | |
Operating Expenses | $129.3M | $151.2M | $186.4M | $202.9M | $185.4M | |
Operating Income | $88.5M | $79.3M | $66.8M | $99.6M | $104M | |
Net Interest Expenses | $3.8M | $3M | $4.3M | $138K | -- | |
EBT. Incl. Unusual Items | $84.7M | $76.3M | $62.5M | $99.5M | $80.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.2M | $17M | $15M | $19.5M | $18.8M | |
Net Income to Company | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Basic EPS (Cont. Ops) | $1.93 | $1.76 | $1.43 | $2.29 | $1.76 | |
Diluted EPS (Cont. Ops) | $1.84 | $1.66 | $1.34 | $2.23 | $1.74 | |
Weighted Average Basic Share | $33.5M | $33.6M | $33.3M | $35M | $35.1M | |
Weighted Average Diluted Share | $35.1M | $35.6M | $35.5M | $35.8M | $35.5M | |
EBITDA | $100.5M | $90.5M | $78.4M | $112.7M | $92.7M | |
EBIT | $89.5M | $79.3M | $66.8M | $101.2M | $81.5M | |
Revenue (Reported) | $686.3M | $723.6M | $806.7M | $928.6M | $898.3M | |
Operating Income (Reported) | $88.5M | $79.3M | $66.8M | $99.6M | $104M | |
Operating Income (Adjusted) | $89.5M | $79.3M | $66.8M | $101.2M | $81.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $295M | $494.5M | $491.7M | $303.2M | $660.5M | |
Short Term Investments | -- | -- | -- | $25.5M | -- | |
Accounts Receivable, Net | $513.5M | $542.1M | $633.1M | $745.4M | $742.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $48.2M | $52.8M | $46.9M | $51.1M | $57M | |
Other Current Assets | $29.6M | $31.2M | $37.6M | $27.4M | $30.3M | |
Total Current Assets | $1.1B | $1.4B | $1.5B | $1.6B | $1.8B | |
Property Plant And Equipment | $258.3M | $358.2M | $357.2M | $368.6M | $348.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Other Intangibles | $41.6M | $32M | $25.5M | $18.3M | $16.8M | |
Other Long-Term Assets | $51.8M | $54.4M | $64.5M | $73.6M | $76.3M | |
Total Assets | $2.8B | $3.1B | $3.2B | $3.3B | $3.6B | |
Accounts Payable | $13.1M | $16.2M | $20.3M | $21.7M | $26M | |
Accrued Expenses | $68M | $63.8M | $67.3M | $74.7M | $82.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $42.7M | $30.8M | $31.9M | $33.9M | $34.1M | |
Other Current Liabilities | $31.5M | $35.3M | $34.1M | $34.7M | $37.7M | |
Total Current Liabilities | $670.2M | $718.1M | $769.5M | $892.8M | $931.8M | |
Long-Term Debt | $286.1M | $297.2M | $315.2M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.5B | $1.6B | $1.3B | $1.3B | |
Common Stock | $345K | $343K | $340K | $355K | $359K | |
Other Common Equity Adj | -$106.4M | -$128.8M | -$176.7M | -$150.5M | -$176.6M | |
Common Equity | $1.4B | $1.6B | $1.7B | $2B | $2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.4B | $1.6B | $1.7B | $2B | $2.3B | |
Total Liabilities and Equity | $2.8B | $3.1B | $3.2B | $3.3B | $3.6B | |
Cash and Short Terms | $295M | $494.5M | $491.7M | $328.7M | $660.5M | |
Total Debt | $286.1M | $297.2M | $315.2M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $233.4M | $271.1M | $238.5M | $244M | $151.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $542.2M | $565.1M | $728.8M | $804.9M | $763.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $83.7M | $97M | $97.7M | $98.1M | $105.4M | |
Total Current Assets | $1.2B | $1.2B | $1.4B | $1.5B | $1.4B | |
Property Plant And Equipment | $249M | $347.9M | $371.9M | $352.5M | $354.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
Other Intangibles | $38.2M | $29.6M | $22.2M | $19.5M | $15.8M | |
Other Long-Term Assets | $47.5M | $53.3M | $62.1M | $80.4M | $86.4M | |
Total Assets | $2.8B | $2.9B | $3.1B | $3.3B | $3.3B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $495.8M | $509.9M | $538.5M | $627.7M | $637.3M | |
Long-Term Debt | $458.8M | $328.9M | $360.6M | $205M | $160M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.3B | $1.4B | $1.3B | $1.2B | |
Common Stock | $342K | $345K | $340K | $357K | $349K | |
Other Common Equity Adj | -$111.7M | -$135M | -$166.9M | -$161.9M | -$162M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.4B | $1.6B | $1.7B | $2.1B | $2.1B | |
Total Liabilities and Equity | $2.8B | $2.9B | $3.1B | $3.3B | $3.3B | |
Cash and Short Terms | $233.4M | $271.1M | $238.5M | $244M | $151.1M | |
Total Debt | $458.8M | $328.9M | $360.6M | $205M | $160M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $210.7M | $235M | $235.5M | $274.9M | $280.1M | |
Depreciation & Amoritzation | $43M | $45.1M | $45.5M | $47.2M | $48.1M | |
Stock-Based Compensation | $22.9M | $23.1M | $25.4M | $29.5M | $38.4M | |
Change in Accounts Receivable | -$18.8M | -$48.6M | -$213.9M | -$280M | -$81.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $327.1M | $355.5M | $188.8M | $224.5M | $395.1M | |
Capital Expenditures | $34.8M | $68.7M | $53.3M | $49.5M | $35.4M | |
Cash Acquisitions | -$25.3M | -$10.4M | -$6.7M | -- | -- | |
Cash From Investing | -$60.1M | -$79.1M | -$60.1M | -$73.8M | -$10.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $289.5M | $402.5M | $165M | $835M | $600M | |
Long-Term Debt Repaid | -$289.5M | -$402.5M | -$165M | -$1.2B | -$600M | |
Repurchase of Common Stock | -$353.6M | -$46.1M | -$85.4M | -$21M | -$10.2M | |
Other Financing Activities | -$6.5M | -$15.5M | -$23.2M | -$19.2M | -$16.1M | |
Cash From Financing | -$360.1M | -$61.7M | -$106M | -$354.7M | -$15.4M | |
Beginning Cash (CF) | $369.4M | $295M | $494.5M | $491.7M | $303.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$93.1M | $214.7M | $22.7M | -$204M | $369.6M | |
Ending Cash (CF) | $295M | $494.5M | $491.7M | $303.2M | $660.5M | |
Levered Free Cash Flow | $292.2M | $286.8M | $135.5M | $175M | $359.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Depreciation & Amoritzation | $11M | $11.2M | $11.6M | $11.4M | $11.2M | |
Stock-Based Compensation | $7.2M | $6M | $6.4M | $8.8M | $9.8M | |
Change in Accounts Receivable | -$91.5M | -$65.1M | -$100.6M | -$121.5M | -$236.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$166.6M | -$203.8M | -$254.2M | -$274.8M | -$465.2M | |
Capital Expenditures | $8M | $12.6M | $18M | $4.6M | $17.8M | |
Cash Acquisitions | -- | -$6.7M | -- | -- | -- | |
Cash From Investing | -$8M | -$19.3M | -$18M | $20.6M | -$17.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $197.5M | $155M | $90M | $280M | $235M | |
Long-Term Debt Repaid | -$27.5M | -$140M | -$45M | -$75M | -$75M | |
Repurchase of Common Stock | -$46.1M | -$3.1M | -$21M | -- | -$182.6M | |
Other Financing Activities | -$7.5M | -$7.7M | -$8.3M | -$8.8M | -$9.7M | |
Cash From Financing | $116.4M | $4.2M | $15.8M | $198.6M | -$32.3M | |
Beginning Cash (CF) | $295M | $494.5M | $491.7M | $303.2M | $660.5M | |
Foreign Exchange Rate Adjustment | -$3.4M | -$4.4M | $3.3M | -$3.6M | $5.9M | |
Additions / Reductions | -$58.1M | -$218.9M | -$256.5M | -$55.6M | -$515.3M | |
Ending Cash (CF) | $233.4M | $271.1M | $238.5M | $244M | $151.1M | |
Levered Free Cash Flow | -$174.6M | -$216.4M | -$272.2M | -$279.5M | -$483M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $218.4M | $229.8M | $223.7M | $307.3M | $261.9M | |
Depreciation & Amoritzation | $43.9M | $45.3M | $46M | $47.1M | $47.8M | |
Stock-Based Compensation | $22.7M | $21.8M | $25.8M | $32M | $39.4M | |
Change in Accounts Receivable | -$56.4M | -$22.3M | -$249.3M | -$300.9M | -$196.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $284M | $318.3M | $138.4M | $203.8M | $204.7M | |
Capital Expenditures | $34.6M | $73.3M | $58.7M | $36.1M | $48.6M | |
Cash Acquisitions | -$25.3M | -$17.1M | -$44K | -- | -- | |
Cash From Investing | -$59.9M | -$90.4M | -$58.8M | -$35.2M | -$48.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $432M | $360M | $100M | $1B | $555M | |
Long-Term Debt Repaid | -$312M | -$515M | -$70M | -$1.2B | -$600M | |
Repurchase of Common Stock | -$350.6M | -$3.1M | -$103.3M | -- | -$192.9M | |
Other Financing Activities | -$17.8M | -$15.8M | -$23.7M | -$19.8M | -$17M | |
Cash From Financing | -$242.8M | -$173.9M | -$94.4M | -$171.8M | -$246.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$18.6M | $53.9M | -$14.8M | -$3.2M | -$90.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $249.5M | $245M | $79.6M | $167.7M | $156.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $64.5M | $59.3M | $47.5M | $80M | $61.8M | |
Depreciation & Amoritzation | $11M | $11.2M | $11.6M | $11.4M | $11.2M | |
Stock-Based Compensation | $7.2M | $6M | $6.4M | $8.8M | $9.8M | |
Change in Accounts Receivable | -$91.5M | -$65.1M | -$100.6M | -$121.5M | -$236.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$166.6M | -$203.8M | -$254.2M | -$274.8M | -$465.2M | |
Capital Expenditures | $8M | $12.6M | $18M | $4.6M | $17.8M | |
Cash Acquisitions | -- | -$6.7M | -- | -- | -- | |
Cash From Investing | -$8M | -$19.3M | -$18M | $20.6M | -$17.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $197.5M | $155M | $90M | $280M | $235M | |
Long-Term Debt Repaid | -$27.5M | -$140M | -$45M | -$75M | -$75M | |
Repurchase of Common Stock | -$46.1M | -$3.1M | -$21M | -- | -$182.6M | |
Other Financing Activities | -$7.5M | -$7.7M | -$8.3M | -$8.8M | -$9.7M | |
Cash From Financing | $116.4M | $4.2M | $15.8M | $198.6M | -$32.3M | |
Beginning Cash (CF) | $295M | $494.5M | $491.7M | $303.2M | $660.5M | |
Foreign Exchange Rate Adjustment | -$3.4M | -$4.4M | $3.3M | -$3.6M | $5.9M | |
Additions / Reductions | -$58.1M | -$218.9M | -$256.5M | -$55.6M | -$515.3M | |
Ending Cash (CF) | $233.4M | $271.1M | $238.5M | $244M | $151.1M | |
Levered Free Cash Flow | -$174.6M | -$216.4M | -$272.2M | -$279.5M | -$483M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.